We are live on ! Find out more
Charles Schwab

Charles Schwab Portfolio holdings

AUM $654B
1-Year Est. Return 26.35%
 

Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.

This Fund
S&P 500
This Quarter Est. Return
-12.91%
1 Year Est. Return
+26.35%
3 Year Est. Return
+83.88%
5 Year Est. Return
+111.55%
10 Year Est. Return
+435.01%
AUM
$131B
AUM Growth
-$19.5B
Cap. Flow
+$2.76B
Cap. Flow %
2.11%
Top 10 Hldgs %
14.61%
Holding
3,199
New
67
Increased
1,772
Reduced
1,049
Closed
53

Top Buys

Rank Stock Value
1
LIN icon
Linde
LIN
+$361M
2
CVS icon
CVS Health
CVS
+$180M
3
CI icon
Cigna
CI
+$158M
4
MSFT icon
Microsoft
MSFT
+$102M
5
AMZN icon
Amazon
AMZN
+$90M

Sector Composition

Rank Sector Weight
1 Technology 15.86%
2 Financials 13.99%
3 Healthcare 13.63%
4 Industrials 10.39%
5 Consumer Discretionary 9.9%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FSB
2626
DELISTED
Franklin Financial Network, Inc.
FSB
$749K ﹤0.01%
28,388
+870
+3% +$28.8K
VPG icon
2627
Vishay Precision Group
VPG
$1.22B
$748K ﹤0.01%
24,738
+1,245
+5% +$40.9K
SHBI icon
2628
Shore Bancshares
SHBI
$819M
$743K ﹤0.01%
51,052
SEI
2629
Solaris Energy Infrastructure
SEI
$3.15B
$740K ﹤0.01%
61,144
+4,879
+9% +$69.3K
RST
2630
DELISTED
ROSETTA STONE INC
RST
$739K ﹤0.01%
45,021
+3,435
+8% +$62.7K
UPL
2631
DELISTED
Ultra Petroleum Corp. Common Stock
UPL
$737K ﹤0.01%
969,377
+54,275
+6% +$68.6K
WLDN icon
2632
Willdan Group
WLDN
$1.04B
$736K ﹤0.01%
21,019
+4,290
+26% +$147K
AGRO icon
2633
Adecoagro
AGRO
$1.44B
$735K ﹤0.01%
105,596
+32,379
+44% +$237K
FRAN
2634
DELISTED
Francesca's Holdings Corporation
FRAN
$735K ﹤0.01%
63,042
+27,761
+79% +$808K
KDNY
2635
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
$731K ﹤0.01%
55,348
-3,667
-6% -$73.3K
KIN
2636
DELISTED
Kindred Biosciences, Inc.
KIN
$725K ﹤0.01%
66,129
CBIO
2637
Crescent Biopharma
CBIO
$537M
$724K ﹤0.01%
764
BWB icon
2638
Bridgewater Bancshares
BWB
$571M
$717K ﹤0.01%
67,934
+40,385
+147% +$467K
CZNC icon
2639
Citizens & Northern Corp
CZNC
$456M
$717K ﹤0.01%
27,109
+1,580
+6% +$40.8K
ORC
2640
Orchid Island Capital
ORC
$1.3B
$716K ﹤0.01%
22,385
MEET
2641
DELISTED
The Meet Group, Inc. Common Stock
MEET
$715K ﹤0.01%
154,424
+6,350
+4% +$27.1K
FMNB icon
2642
Farmers National Banc Corp
FMNB
$939M
$714K ﹤0.01%
55,993
+1,400
+3% +$18.9K
DHT icon
2643
DHT Holdings
DHT
$2.99B
$713K ﹤0.01%
181,674
+8,074
+5% +$37.4K
ENIC icon
2644
Enel Chile
ENIC
$6.14B
$709K ﹤0.01%
143,198
-95,263
-40% -$445K
SYRS
2645
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
$708K ﹤0.01%
12,703
-203
-2% -$15.4K
WTBA icon
2646
West Bancorporation
WTBA
$478M
$707K ﹤0.01%
36,990
ZVO
2647
DELISTED
Zovio Inc. Common Stock
ZVO
$707K ﹤0.01%
100,758
-1,516
-1% -$12.9K
MNOV icon
2648
MediciNova
MNOV
$65.5M
$705K ﹤0.01%
86,235
CATC
2649
DELISTED
CAMBRIDGE BANCORP
CATC
$701K ﹤0.01%
8,410
+493
+6% +$41.8K
RARX
2650
DELISTED
Ra Pharmaceuticals, Inc. Common Stock
RARX
$701K ﹤0.01%
38,510
+7,300
+23% +$115K

Similar funds

Charles Schwab's Q4 2018 Portfolio in Review

As of Q4 2018, Charles Schwab held 3,199 positions worth $131B, down 13% from $150B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Trading was light in Q4 2018: portfolio turnover was 3.8%. Charles Schwab opened 67 new positions and exited 53, leaving the 3,199-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 17% a quarter earlier, followed by Financials and Healthcare.

  • Charles Schwab's largest Q4 2018 buy was Linde: 2,286,208 shares worth $357M.
  • Charles Schwab added most to CVS Health in Q4 2018, an estimated $180M increase.
  • Charles Schwab's biggest Q4 2018 reduction was Qualcomm, cutting an estimated $42.7M.
  • Charles Schwab fully exited Express Scripts Holding Company in Q4 2018, selling an estimated $301M.
  • Charles Schwab's ten largest holdings make up 15% of its $131B portfolio in Q4 2018.
  • Charles Schwab opened 67 new positions and closed 53 in Q4 2018.
  • Charles Schwab's portfolio value fell 13% quarter-over-quarter to $131B.

Based on Charles Schwab's 13F filing for Q4 2018, filed 14 Feb 2019.